Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
13/03/2026
Brilliance China Automotive: It is projected that the pre-tax profit audited by 2025 will drop by as much as 50%.
Latest
4 m ago
On March 13th, Apple announced that it will lower the commission rate for the Chinese App Store starting from March 15th. Baidu stated that this adjustment not only responds to the long-standing concerns of Chinese users and developers, but also signals a more open and positive development for the app ecosystem.
5 m ago
JiuDian Pharmaceuticals: After the implementation of centralized purchasing, product prices have decreased, putting certain pressure on profit margins in the short term.
5 m ago
According to the report by the Japan Broadcasting Corporation, Tokyo Electric Power Company stated that there are no abnormalities in the nuclear reactor and there are no safety hazards.
6 m ago
According to the Japan Broadcasting Corporation, Tokyo Electric Power Company stopped the generator of the No. 6 reactor at the Kashiwazaki-Kariwa nuclear power plant after an alert indicated a minor electrical leakage.
6 m ago
Xuantai Pharmaceuticals: Collaborative product Enzalutamide tablets approved by National Medical Products Administration.
See all latest